CHICAGO - Gadopiclenol is emerging as an alternative gadolinium-based MRI contrast agent. To learn more about the product's potential, we spoke with Prof. Dr. Christiane Kuhl from the University Hospital Aachen in Germany at RSNA 2022.
Kuhl provides research update on gadolinium-based contrast agent
Dec 4, 2022
Latest in Market Analysis